Medicare
- Blog Post
Presentations by Staff of CBO's Health Analysis Division
This week, five analysts from CBO's Health Analysis Division are presenting their work at the 11th Annual Conference of the American Society of Health Economists ("ASHEcon") in Austin, Texas.
- Report
The Budget and Economic Outlook: 2022 to 2032
In CBO’s projections, assuming that current laws generally remain unchanged, the federal deficit totals $1.0 trillion in fiscal year 2022 and averages $1.6 trillion per year from 2023 to 2032. Real GDP grows by 3.1 percent this year.
- Report
Budgetary Effects of a Policy That Would Lower the Age of Eligibility for Medicare to 60
CBO and the staff of the Joint Committee on Taxation estimate that lowering the age of Medicare eligibility to 60 would increase federal budget deficits, change primary sources of health insurance, and increase the number of people insured.
- Report
Testimony on a Single-Payer Health Care System That Is Based on Medicare’s Fee-for-Service Program
CBO Director Phillip Swagel testifies before the Senate Budget Committee.
- Report
The Economic Effects of Waiting to Stabilize Federal Debt
CBO analyzes the economic effects of waiting to stabilize federal debt. The longer action is delayed, the larger the policy changes needed to stabilize debt. The timing and type of policy would determine its effects on different age and income groups.
- Presentation
A Discussion of Recent Research on Health Care Prices: Prescription Drugs, Hospitals’ Services, and Physicians’ Services
Presentation by Michael Cohen, an analyst in CBO’s Health Analysis Division, and Tamara Hayford, Chief of CBO’s Health Policy Studies Unit, at the Congressional Research Service.
- Presentation
Variation in Prices for Hospitals’ Services
Presentation by Michael Cohen, an analyst in CBO’s Health Analysis Division, at the American Academy of Actuaries.
- Cost Estimate
Estimated Budgetary Effects of H.R. 6833, the Affordable Insulin Now Act
As posted on the Website of the House Committee on Rules on March 28, 2022
- Presentation
The Contribution of Changes in Drug Mix and Price Growth to the Rising Costs of Brand-Name Drugs in Medicare Part D
Presentation by Tamara Hayford, Chief of CBO’s Health Policy Studies Unit, at the Association for Public Policy Analysis & Management 2021 Annual Research Meeting.
- Report
Additional Information Concerning the Budgetary Effects of H.R. 3076, the Postal Service Reform Act of 2022
In a letter to Senator Scott, CBO addresses several questions concerning the agency's assessment of the budgetary effects of H.R. 3076, the Postal Service Reform Act of 2022, which was transmitted on February 4, 2022.